Quantbot Technologies LP Compugen LTD Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $6,899 - $11,600	-2,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.09 - $7.16 $10,225 - $17,900	2,500 New	2,500 $10,000
Q2 2021 Aug 12, 2021	SELL	$6.87 - $9.16 $352,485 - $469,981	-51,308 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$7.67 - $13.77 $114,413 - $205,407	-14,917 Reduced 22.52%	51,308 $440,000
Q4 2020 Feb 12, 2021	BUY	$12.07 - $17.95 $786,336 - $1.17 Million	65,148 Added 6049.03%	66,225 $801,000
Q3 2020 Nov 16, 2020	SELL	$14.16 - $19.45 $41,389 - $56,852	-2,923 Reduced 73.08%	1,077 $17,000
Q2 2020 Aug 13, 2020	BUY	$6.97 - $17.12 $27,880 - $68,480	4,000 New	4,000 $60,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.